Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Molecular Graphics & Modelling|February 22, 2011
In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptorSantiago Vilar, Joel Karpiak, Barkin Berk, et al.Arzneimittel-Forschung|June 13, 2009
Design and synthesis of some (S)-2-(6-methoxynaphthalen-2-yl)-N-substituted ethyl propanamide derivatives as potent non-ulcerogenic anti-inflammatory and analgesic agentsBarkin Berk, Dilek Demir Erol, Esra Kupeli, et al.Archiv Der Pharmazie|March 10, 2018
Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluationMerve Ertas, Zafer Sahin, Barkin Berk, et al.Journal of Molecular Graphics & Modelling|December 15, 2010
Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico modelsSantiago Vilar, Giulio Ferino, Sharangdhar S Phatak, et al.Farmaco (Societa Chimica Italiana : 1989)|October 26, 2005
New 8-substituted xanthiene derivatives as potent bronchodilatorsBarkin Berk, Hülya Akgün, Kevser Erol, et al.Zeitschrift Fur Naturforschung. C, Journal of Biosciences|December 13, 2021
Novel benzofurane-pyrazole derivatives with anti-inflammatory, cyclooxygenase inhibitory and cytotoxicity evaluationZafer Sahin, Yağmur Özhan, Hande Sipahi, et al.Drug Development Research|October 22, 2018
Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitorsZafer Sahin, Merve Ertas, Ceysu Bender, et al.European Journal of Medicinal Chemistry|January 10, 2021
Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibitionZafer Sahin, Sevde Nur Biltekin, Leyla Yurttas, et al.Archiv Der Pharmazie|September 3, 2019
Potent ribonucleotide reductase inhibitors: Thiazole-containing thiosemicarbazone derivativesMerve Ertas, Zafer Sahin, Emre F Bulbul, et al.Journal of Medicinal Chemistry|May 8, 2010
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modificationsHiroshi Maruoka, Matthew O Barrett, Hyojin Ko, et al.Pageof 1